DexCom, Inc.
USD72.77
-0.68 (-0.93%)
CEO
Jacob Steven Leach
IPO Date
2005-04-14
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$73.00
Prev. Close
$73.45
Day Low
$71.95
Day High
$73.25
52W Low
$54.11
52W High
$89.98
Market Cap
$28.08B
Volume
4.00M
| 54.6 |
| 31 Dec 2023 | FY | 63.2% | 14.9% | 26.2% | 8.6% | 1.25 | 2.84 | 88.5 |
| 31 Dec 2022 | FY | 64.7% | 11.7% | 16.0% | 6.3% | 0.98 | 1.99 | 137.5 |
| 31 Dec 2021 | FY | 68.6% | 6.3% | 6.9% | 3.2% | 0.81 | 5.11 | 335.7 |
| 31 Dec 2020 | FY | 66.4% | 25.6% | 27.0% | 11.5% | 1.01 | 5.58 | 70.7 |
| 31 Dec 2019 | FY | 63.1% | 6.8% | 11.5% | 4.2% | 1.30 | 5.47 | 197.1 |
| 31 Dec 2018 | FY | 64.4% | -12.3% | -19.2% | -6.6% | 1.54 | 7.64 | -83.1 |
| 31 Dec 2017 | FY | 68.5% | -7.0% | -12.0% | -5.6% | 0.70 | 5.36 | -98.7 |
| 31 Dec 2016 | FY | 66.0% | -11.4% | -23.1% | -16.3% | -0.14 | 2.73 | -76.1 |
| 23.2 |
| 30 Jun 2025 | Q2 | 59.5% | 15.5% | 7.0% | 2.5% | 1.00 | 1.52 | 47.6 |
| 31 Mar 2025 | Q1 | 56.9% | 10.2% | 4.7% | 1.6% | 1.14 | 1.50 | 63.3 |
| 31 Dec 2024 | Q4 | 58.7% | 13.6% | 7.2% | 2.3% | 1.23 | 1.47 | 51.2 |
| 30 Sept 2024 | Q3 | 59.7% | 13.5% | 6.8% | 2.1% | 1.31 | 2.46 | 49.1 |
| 30 Jun 2024 | Q2 | 62.4% | 14.3% | 5.9% | 2.1% | 1.07 | 2.82 | 78.0 |
| 31 Mar 2024 | Q1 | 61.0% | 15.9% | 6.5% | 2.3% | 1.15 | 2.90 | 91.9 |
| 31 Dec 2023 | Q4 | 63.5% | 24.8% | 12.4% | 4.1% | 1.25 | 2.84 | 46.5 |
| 30 Sept 2023 | Q3 | 63.9% | 12.4% | 5.3% | 1.8% | 1.17 | 2.80 | 74.7 |